BBC News |
Arizona's AG joins 44 other states in reaching settlement over asthma drug
KVOA Tucson News Arizona, along with 44 other states, reached a $105 million settlement with GlaxoSmithKline, LLC to resolve allegations that the company unlawfully promoted its asthma drug, Advair®, and antidepressant drugs, Paxil® and Wellbutrin®. For example, GSK … GlaxoSmithKline to pay $105 million over improper drug marketing Illinois among 45 states settling off-label dispute with GlaxoSmithKline GlaxoSmithKline in $105 million settlement with US states over marketing |
View full post on asthma – Google News